Article Details
Retrieved on: 2022-06-14 17:38:44
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Immunicom, Inc., a privately held clinical-stage biotechnology company with a transformative immuno-oncology platform, has been awarded $2 million ...
Article found on: www.bakersfield.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here